Assura PLC (LON:AGR)‘s stock had its “hold” rating reiterated by equities researchers at Liberum Capital in a report issued on Tuesday. They presently have a GBX 60 ($0.75) price objective on the real estate investment trust’s stock. Liberum Capital’s price objective would suggest a potential upside of 0.76% from the company’s previous close.

Separately, Peel Hunt restated a “hold” rating and set a GBX 55 ($0.69) target price on shares of Assura PLC in a report on Tuesday.

Assura PLC (LON:AGR) opened at 60.00 on Tuesday. The company’s market capitalization is GBX 981.87 million. Assura PLC has a one year low of GBX 48.08 and a one year high of GBX 61.00. The company’s 50-day moving average is GBX 58.85 and its 200 day moving average is GBX 57.61.

About Assura PLC

Assura plc is a United Kingdom-based healthcare real estate investment trust (REIT). The Company is a primary care property investor and developer. The Company develops, invests and manages a portfolio of primary care medical centers across the United Kingdom. The Company’s property portfolio includes Alwoodley Medical Centre, Leeds; Fleetwood Health and Wellbeing Centre, Fleetwood; Frome Medical Practice, Frome; Claremont Medical Centre, Surbiton; Elbury Moor Medical Centre; Grey Gable Surgery; Trellech Surgery; Bewdley Medical Centre; Malmesbury Primary Care Centre, Malmesbury, and Urmston Group Practice, Urmston.

Receive News & Stock Ratings for Assura PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura PLC and related stocks with our FREE daily email newsletter.